M. Lambert

Physiology · Proceedings of the National Academy of Sciences of the United States of America · 2003–2009

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Physiology — 45 citations into it; #2,268 of 2,276 by trust here, #743 by citations
• Cellular and Molecular Neuroscience — 31 citations into it

Whom M. Lambert trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Selkoe

Who trusts M. Lambert overall

1. F. D. De Felice

Papers from M. Lambert's perspective

Ordered by how strongly the researchers M. Lambert trusts endorse each paper. Same corpus, a different order for every researcher.

1. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis (Science)
2. Pathways towards and away from Alzheimer's disease (Nature)
3. A specific amyloid-beta protein assembly in the brain impairs memory. (Nature)
4. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo (Nature)
5. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. (Neuron)
6. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model (Nature Neuroscience)
7. Regulation of NMDA receptor trafficking by amyloid-β (Nature Neuroscience)
8. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. (Annual Review of Neuroscience)
9. Inhibition of Activity-Dependent Arc Protein Expression in the Rat Hippocampus Impairs the Maintenance of Long-Term Potentiation and the Consolidation of Long-Term Memory (Journal of Neuroscience)
10. Morphological changes in dendritic spines associated with long-term synaptic plasticity. (Annual Review of Neuroscience)

Their papers

• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss (2003) — 1,118 citations
• Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers (2009) — 616 citations
• Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* (2007) — 904 citations
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers (2004) — 861 citations